|
Ind Swift Laboratories was founded in 1995. The company is engaged in the manufacture of Active Pharmaceutical Ingredients (API). The Company operates in a single business segment, Bulk Drugs and Pharmaceuticals. Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorvastatin (anticholestrol), Fexofenadine (antihistamine), Clopidogrel (anticholestrol), Nitazoxanide (antidiarrheal), Pioglitazone (antidiabetic), Letrozole and Anastrozole (anticancer), Venlafaxine (antidepressants) and Quetipine and Aripirazole (antipsychotic). Over a short period, the company has emerged as a respectable and dependable supplier of Bulk-Actives in more than 40 countries.
Ind Swift Laboratories is publically traded on BSE and NSE.
Below you will find details about Ind Swift Laboratories Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
|
